The Factory Floor: Aurobindo Receives Another Form 483
Biocon, Indoco and Lupin Report Successful FDA Inspections
Aurobindo has received further Form 483s from the FDA, while Biocon has received an EIR for its Bengaluru facility. The FDA has also successfully concluded inspections for Indoco and Lupin, while ANI, Aptar and MicroSphere have made strategic moves.
